|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 318,500 KRW | +2.58% |
|
+1.59% | -9.65% |
Hanmi Pharm. Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 2,570.12 million compared to KRW 848 million a year ago.
Net income was KRW 43,147.73 million compared to KRW 19,515 million a year ago. Basic earnings per share from continuing operations was KRW 3,399.0196 compared to KRW 1,535.2941 a year ago. Basic earnings per share was KRW 3,399.0196 compared to KRW 1,535.2941 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.65% | 2.94B | |
| +20.22% | 43.75B | |
| +23.60% | 22.06B | |
| +13.30% | 14.46B | |
| +12.97% | 13.62B | |
| +38.09% | 11.61B | |
| -9.38% | 6.9B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +9.64% | 5.32B |
HANMI PHARM. CO., LTD. 
